New treatment options in status epilepticus: a critical review on intravenous levetiracetam (Q34409333)

2 August 2017

1 reference

title

New treatment options in status epilepticus: a critical review on intravenous levetiracetam (English)

1 reference

2 August 2017

1 reference

1

Eugen Trinka

2 references

2 August 2017

ORCID Public Data File 2021

Judith Dobesberger

series ordinal

2

object named as

Judith Dobesberger

1 reference

2 August 2017

publication date

1 March 2009

1 reference

Therapeutic advances in neurological disorders

2 August 2017

published in

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

79-91

1 reference

Review: Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Intensive care unit management of patients with status epilepticus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

The use of valproate and new antiepileptic drugs in status epilepticus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Anticonvulsant therapy for status epilepticus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Termination of complex partial status epilepticus by intravenous levetiracetam

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

EFNS guideline on the management of status epilepticus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Standards of care for adults with convulsive status epilepticus: Belgian consensus recommendations.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Levetiracetam in porphyric status epilepticus: a case report

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Clinical pharmacokinetics of levetiracetam

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

The pharmacokinetic characteristics of levetiracetam

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Recent developments in treatment of status epilepticus: a review.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

Termination of absence status epilepticus by low-dose intravenous levetiracetam

6 July 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Intravenous levetiracetam in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

The use of levetiracetam in refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Levetiracetam opposes the action of GABAA antagonists in hypothalamic neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Epilepsy and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Review: Recent and future advances in the treatment of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Determinants of success in the use of oral levetiracetam in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Levetiracetam as a treatment option in non-convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Dynamic changes of ictal high-frequency oscillations in neocortical epilepsy: using multiple band frequency analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Intravenous levetiracetam terminates refractory focal status epilepticus

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

The value of levetiracetam in epileptic status

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002622

The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status Epilepticus

27 October 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

The proceedings of the First London Colloquium on Status Epilepticus—University College London, April 12–15, 2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

In Situ Metabolism of Levetiracetam in Blood of Patients with Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1756285608100460

Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats

21 January 2018

1 reference

12 December 2020

Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission

1 reference

12 December 2020

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

1 reference

12 December 2020

ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo

1 reference

12 December 2020

Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures

1 reference

12 December 2020

The proceedings of the First London Colloquium on Status Epilepticus--University College London, April 12-15, 2007. Introduction

1 reference

12 December 2020

IV levetiracetam in the management of non-convulsive status epilepticus

1 reference

12 December 2020

Sodium valproate vs phenytoin in status epilepticus: a pilot study

1 reference

12 December 2020

Randomized study of intravenous valproate and phenytoin in status epilepticus

1 reference

12 December 2020

Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study

1 reference

12 December 2020

Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model

1 reference

12 December 2020

Use of levetiracetam in hospitalized patients

1 reference

12 December 2020

Identifiers

DOI

10.1177/1756285608100460

1 reference

2 August 2017

1 reference

2 August 2017

1 reference